ライフサイエンスコーパス: brain magnetic resonance imaging

1 ll patients showed a new medullary lesion on brain magnetic resonance imaging.

2 e on the basis of core clinical features and brain magnetic resonance imaging.

3 lvement in pure AMN patients who have normal brain magnetic resonance imaging.

4 in patients with a gadolinium enhancement on brain magnetic resonance imaging.

5 ignificant decreases in enhancing lesions on brain magnetic resonance imaging.

6 lerosis or >1 new or enlarging T2 lesions on brain magnetic resonance imaging.

7 ve battery was administered; 1075 also had a brain magnetic resonance imaging.

8 solution dynamic [(11) C]FMZ PET imaging and brain magnetic resonance imaging.

9 nant axial rigidity, and midbrain atrophy on brain magnetic resonance imaging.

10 inical history and the hot cross bun sign on brain magnetic resonance imaging.

11 determination, [18F]MNI-659 PET imaging, and brain magnetic resonance imaging.

12 or disorder with underlying abnormalities on brain magnetic resonance imaging.

13 a subset of 1901 participants with available brain magnetic resonance imaging (1999-2005), we further

14 ith 1-year Psychomotor Development Index and brain magnetic resonance imaging abnormalities among inf

15 ed individuals aged between 45 and 98 years, brain magnetic resonance imaging and genotyping was perf

16 Alcoholic men received brain magnetic resonance imaging and laboratory assessme

17 Subjects who agreed to participate had a brain magnetic resonance imaging and positron emission t

18 Thorough clinical evaluations, including brain magnetic resonance imaging and sensory evoked pote

19 and weeks 10 and 20, participants underwent brain magnetic resonance imaging and spectroscopy protoc

20 nts gave written informed consent to undergo brain magnetic resonance imaging and the Addenbrooke's C

21 presence of brain injury on the preoperative brain magnetic resonance imaging and the trajectory of p

22 tions, anti-CASPR2 antibodies specificities, brain magnetic resonance imaging, and CSF analyses, canc

23 and nerve morphology, longitudinal study of brain magnetic resonance imaging, and glycogen branching

24 and retinal function, had normal findings on brain magnetic resonance imaging, and had normal cerebro

25 isorders, Fourth Edition [DSM-IV] criteria), brain magnetic resonance imaging, and proton magnetic re

26 Neuropsychological data, structural brain magnetic resonance imaging, and task-free function

27 onset parkinsonism-dystonia with distinctive brain magnetic resonance imaging appearances and neurode

28 sability Status Scale score, spinal cord and brain magnetic resonance imaging, AQP4-ab titers, pain l

29 ll of lifetime smoking data and a structural brain magnetic resonance imaging at age 73 years from wh

30 motherapy underwent clinical examination and brain magnetic resonance imaging at the following three

31 presentation of tuberculosis and appeared on brain magnetic resonance imaging at the time of presenta

32 morphometry to examine group differences in brain magnetic resonance imaging atrophy patterns.

33 3 weeks, with standardized naming tests and brain magnetic resonance imaging before and after therap

34 f clinically definite multiple sclerosis and brain magnetic resonance imaging changes in subgroups ba

35 We performed brain magnetic resonance imaging, cognitive tests, and n

36 ess this, we meta-analyzed three-dimensional brain magnetic resonance imaging data from 1728 MDD pati

37 on auditory scene analysis tasks, structural brain magnetic resonance imaging data from the patient c

38 d 70 years of age as well as high-resolution brain magnetic resonance imaging data obtained at approx

39 In 7 of 8 patients, brain magnetic resonance imaging demonstrated deep foci

40 urological examination, and abnormalities on brain magnetic resonance imaging did not differ between

41 Brain magnetic resonance imaging displayed T2-weighted t

42 and associated with clinical investigations (brain magnetic resonance imaging, electroencephalography

43 linical demyelinating event in patients with brain magnetic resonance imaging evidence of subclinical

44 first demyelinating event, 383 patients with brain magnetic resonance imaging evidence of subclinical

45 On brain magnetic resonance imaging examination, patients d

46 Based on brain magnetic resonance imaging findings in these patie

47 Brain magnetic resonance imaging findings were abnormal

48 Brain magnetic resonance imaging findings were normal.

49 typical facial appearance and characteristic brain magnetic resonance imaging findings.

50 follow-up with neuropsychological tests and brain magnetic resonance imaging for 3 years, and 87 pat

51 optic glioma were twice as likely to undergo brain magnetic resonance imaging for visual symptoms and

52 Ophthalmologic examinations, brain magnetic resonance imaging, full-field and multifo

53 Subclinical acute ischaemic lesions on brain magnetic resonance imaging have recently been desc

54 omen, 17% blacks, 68% hypertension, 3600 had brain magnetic resonance imaging in 1992-1993, survival

55 perivascular radial enhancement was found on brain magnetic resonance imaging in 53%.

56 lination with white matter hyperintensity on brain magnetic resonance imaging in one-third of the coh

57 velopment of new brain lesions observed with brain magnetic resonance imaging in relapsing-remitting

58 In addition, soldiers had structural brain magnetic resonance imaging, including diffusion te

59 Brain magnetic resonance imaging is an important tool in

60 Brain magnetic resonance imaging is widely used as a dia

61 Using prospective structural brain magnetic resonance imaging, large-scale corticocor

62 onset of fluctuating neurological signs and brain magnetic resonance imaging lesions simulating mult

63 ion, relapse number, and increased volume of brain magnetic resonance imaging lesions.

64 prior year and 1 to 15 gadolinium-enhancing brain magnetic resonance imaging lesions.

65 Standardized brain magnetic resonance imaging/magnetic resonance angi

66 Brain magnetic resonance imaging may play a role in the

67 The brain magnetic resonance imaging measures included: T(1)

68 Clinical and brain magnetic resonance imaging measures of disease act

69 Brain magnetic resonance imaging measures of HV, TCV, an

70 (standard deviation, 4.7) years) with 1.5-T brain magnetic resonance imaging measures of infarct-lik

71 We examined the balance between brain magnetic resonance imaging measures of the two mos

72 index, would be associated with preclinical brain magnetic resonance imaging (MRI) and neuropsycholo

73 To investigate the prevalence of brain magnetic resonance imaging (MRI) and subclinical a

74 ldhood-onset schizophrenia shows progressive brain magnetic resonance imaging (MRI) changes during ad

75 ly to have normal appearing basal ganglia on brain magnetic resonance imaging (MRI) compared to minor

76 th detailed placental histology and neonatal brain magnetic resonance imaging (MRI) data at term equi

77 Brain magnetic resonance imaging (MRI) demonstrates a 1.

78 This study attempts to determine which fetal brain magnetic resonance imaging (MRI) features might be

79 [RNFL] thickness and macular volume) and 3T brain magnetic resonance imaging (MRI) for posterior vis

80 In addition, 360 participants underwent brain magnetic resonance imaging (MRI) for SBI detection

81 T2 lesions or contrast-enhancing lesions on brain magnetic resonance imaging (MRI) in relapsing mult

82 Brain magnetic resonance imaging (MRI) is a method of ch

83 Brain magnetic resonance imaging (MRI) scans clinically

84 Structural T1-weighted brain magnetic resonance imaging (MRI) scans from 2148 M

85 s have discussed incidental disease found on brain magnetic resonance imaging (MRI) scans that had be

86 idually matched for age and gender, received brain magnetic resonance imaging (MRI) scans.

87 Brain magnetic resonance imaging (MRI) showed a complex,

88 Prospective brain magnetic resonance imaging (MRI) studies have foun

89 Recent anatomical brain magnetic resonance imaging (MRI) studies show a st

90 Brain magnetic resonance imaging (MRI) uniformly reveale

91 Neuropsychological functioning and brain magnetic resonance imaging (MRI) were evaluated in

92 All patients underwent EEG and brain magnetic resonance imaging (MRI) while they were a

93 Neurological examinations, brain magnetic resonance imaging (MRI), and immunology t

94 21 age-matched full-term controls underwent brain magnetic resonance imaging (MRI), as well as neuro

95 tients underwent neurocognitive evaluations, brain magnetic resonance imaging (MRI), echocardiograms,

96 py, optical imaging (multiphoton), and whole brain magnetic resonance imaging (MRI), facilitating mol

97 ssion of clinical features and serum sodium, brain magnetic resonance imaging (MRI), positron emissio

98 esting, vascular risk factor assessment, and brain magnetic resonance imaging (MRI).

99 We performed neurologic evaluations and brain magnetic resonance imaging (MRI).

100 t in the 24 patients with normal T2-weighted brain magnetic resonance imaging (MRI).

101 Participants were invited to undergo brain magnetic resonance imaging (MRI).

102 l retina (n = 2) and hyperintense lesions on brain magnetic resonance imaging (n = 2).

103 Brain magnetic resonance imaging on a small number of ch

104 Regression models for the brain magnetic resonance imaging outcomes also were adju

105 .02) and involvement of deep gray nuclei on brain magnetic resonance imaging (P = .03).

106 based on type of presenting event, baseline brain magnetic resonance imaging parameters, and demogra

107 also was seen in subgroups based on baseline brain magnetic resonance imaging parameters, gender, and

108 newborns with critical CHD were studied with brain magnetic resonance imaging preoperatively and post

109 es, with a mean number of 16 Gad+ lesions on brain magnetic resonance imaging (range, 6-40).

110 esults of audiology testing, echocardiogram, brain magnetic resonance imaging, renal ultrasound, and

111 Brain magnetic resonance imaging results were negative.

112 Discharge outcomes and brain magnetic resonance imaging results were obtained.

113 Brain magnetic resonance imaging revealed bilateral pont

114 Brain magnetic resonance imaging revealed nonprogressive

115 Brain magnetic resonance imaging revealed that patients

116 Brain magnetic-resonance imaging revealed polymicrogyria

117 ented with headache, nausea, and vomiting; a brain magnetic resonance imaging scan showed left anteri

118 A brain magnetic resonance imaging scan was negative.

119 uestionnaire scores, and T2 lesion volume on brain magnetic resonance imaging scan.

120 ), from an initial group of 58 who underwent brain magnetic resonance imaging scanning while in treat

121 Brain magnetic resonance imaging scans and an autopsy re

122 Brain magnetic resonance imaging scans and an autopsy re

123 er's Disease Neuroimaging Initiative who had brain magnetic resonance imaging scans at baseline and 2

124 examine cortical change, we used anatomical brain magnetic resonance imaging scans for 15 patients w

125 9 participants underwent repeated structural brain magnetic resonance imaging scans from September 17

126 ter thickness and surface area measures from brain magnetic resonance imaging scans of 6503 individua

127 nd JCV polymerase chain reaction testing and brain magnetic resonance imaging scans should be repeate

128 Brain magnetic resonance imaging scans were acquired and

129 A total of 131 brain magnetic resonance imaging scans were acquired for

130 Anatomic brain magnetic resonance imaging scans were acquired for

131 Structural brain magnetic resonance imaging scans were acquired fro

132 Structural and functional brain magnetic resonance imaging scans were acquired in

133 Anatomic brain magnetic resonance imaging scans were acquired wit

134 Anatomic brain magnetic resonance imaging scans were obtained for

135 Structural brain magnetic resonance imaging scans were performed at

136 (n = 24) and control men (n = 25) received 2 brain magnetic resonance imaging scans, on average 4 yea

137 on subjects had initial and 2-year follow-up brain magnetic resonance imaging scans.

138 cALD demonstrated an inverse correlation to brain magnetic resonance imaging severity score (R2 = 0.

139 On brain magnetic resonance imaging, she was found to have

140 Brain magnetic resonance imaging showed global brain atr

141 Brain magnetic resonance imaging showed increased T2 and

142 Brain magnetic resonance imaging showed iron in the subs

143 Brain magnetic resonance imaging showed positive-embolic

144 Brain magnetic resonance imaging showed subtle abnormali

145 Overall, 17 of 24 patients (71%) with brain magnetic resonance imaging studies had abnormaliti

146 Previous structural brain magnetic resonance imaging studies suggest volume

147 Brain magnetic resonance imaging study of 11 affected pa

148 Our data suggest childhood brain magnetic resonance imaging surveillance is justifi

149 We yoked anatomical brain magnetic resonance imaging to a randomized, double

150 Here, we performed brain magnetic resonance imaging to measure volumes of t

151 glia lesions were the most common finding in brain magnetic resonance imaging, usually associated wit

152 Brain magnetic resonance imaging was abnormal in 2 cases

153 Brain magnetic resonance imaging was carried out at 1.5T

154 Ophthalmologic examination was normal, the brain magnetic resonance imaging was not suggestive of P

155 Prospective brain magnetic resonance imaging was performed at four t

156 analysis of whole-brain 3-T high-resolution brain magnetic resonance imaging was used to determine t

157 Hemosiderin foci on brain magnetic resonance imaging were associated with lo

158 Neuropsychological assessment and brain magnetic resonance imaging were performed at the l

159 it and approximately 7 years later underwent brain magnetic resonance imaging with automated volumetr